<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nogr</journal-id><journal-title-group><journal-title xml:lang="ru">Экспериментальная и клиническая гастроэнтерология</journal-title><trans-title-group xml:lang="en"><trans-title>Experimental and Clinical Gastroenterology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-8658</issn><publisher><publisher-name>«Global Media Technologies»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.31146/1682-8658-ecg-203-7-45-53</article-id><article-id custom-type="elpub" pub-id-type="custom">nogr-2010</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ ГАСТРОЭНТЕРОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL GASTROENTEROLOGY</subject></subj-group></article-categories><title-group><article-title>Эндотелиальная дисфункция у пациентов с неалкогольной жировой болезнью печени</article-title><trans-title-group xml:lang="en"><trans-title>Endothelial dysfunction in patients with non-alcoholic fatty liver disease</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тирикова</surname><given-names>Олеся Владимировна</given-names></name><name name-style="western" xml:lang="en"><surname>Tirikova</surname><given-names>Olesya V.</given-names></name></name-alternatives><email xlink:type="simple">otirikova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Козлова</surname><given-names>Наталия Михайловна</given-names></name><name name-style="western" xml:lang="en"><surname>Kozlova</surname><given-names>Natalia M.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Елисеев</surname><given-names>Сергей Михайлович</given-names></name><name name-style="western" xml:lang="en"><surname>Eliseev</surname><given-names>Sergey M.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Акимова</surname><given-names>Валентина Ивановна</given-names></name><name name-style="western" xml:lang="en"><surname>Akimova</surname><given-names>Valentina I.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гумеров</surname><given-names>Руслан Рифавич</given-names></name><name name-style="western" xml:lang="en"><surname>Gumerov</surname><given-names>Ruslan R.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Карелина</surname><given-names>Наталья Владимировна</given-names></name><name name-style="western" xml:lang="en"><surname>Karelina</surname><given-names>Natalia V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Венцак</surname><given-names>Елена Владимировна</given-names></name><name name-style="western" xml:lang="en"><surname>Ventsak</surname><given-names>Elena V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО Иркутский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Irkutsk State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>07</day><month>10</month><year>2022</year></pub-date><volume>0</volume><issue>7</issue><fpage>45</fpage><lpage>53</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Тирикова О.В., Козлова Н.М., Елисеев С.М., Акимова В.И., Гумеров Р.Р., Карелина Н.В., Венцак Е.В., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Тирикова О.В., Козлова Н.М., Елисеев С.М., Акимова В.И., Гумеров Р.Р., Карелина Н.В., Венцак Е.В.</copyright-holder><copyright-holder xml:lang="en">Tirikova O.V., Kozlova N.M., Eliseev S.M., Akimova V.I., Gumerov R.R., Karelina N.V., Ventsak E.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.nogr.org/jour/article/view/2010">https://www.nogr.org/jour/article/view/2010</self-uri><abstract><p>Цель исследования: изучение сосудистой реакции в ответ на проведение пробы реактивной гиперемии у пациентов с НАЖБП и выявление взаимосвязи жирового поражения печени с эндотелиальной дисфункцией. Методы: Исследование проводилось на базе ОГБУЗ «Иркутская Областная ордена «Знак Почета» клиническая больница», АГБУЗ «Ангарская городская клиническая больница № 1» и консультативно-диагностического отделения № 1 ОГБУЗ «Иркутская Областная Инфекционная Клиническая больница». Объект исследования: пациенты с НАЖБП и практически здоровые добровольцы. Всем респондентам для диагностики фиброза печени была выполнена непрямая эластометрия, а для оценки эндотелиальной дисфункции проба реактивной гиперемии (ПРГ) по методике Celermajer [<xref ref-type="bibr" rid="cit15">15</xref>]. Статистический анализ полученных данных выполняли в программе Statistica 13 for Windows. Результаты: Исследование проведено в период 2014-2016 гг. Обследовано 64 человека в возрасте от 25 до 64 лет с подтвержденным диагнозом НАЖБП и 23 практически здоровых добровольца в возрасте от 25 до 44 лет, вошедших в группу клинического сравнения. Выводы: 1. Фиброзные изменения печени встречались чаще среди лиц средней возрастной группы и были более выражены, чем среди лиц молодого возраста; 2. Выявлена корреляция жирового поражения печени с эндотелиальной дисфункции - чем больше степень фиброза, тем сильнее патологическая реакция сосудистой стенки; 3. Доказано наличие при стеатозе эндотелиальной дисфункции, а соответственно и риска кардио-васкулярных событий. Заключение: полученные результаты указывают на связь патологических процессов: поражения печени при НАЖБП и развития ССЗ.</p></abstract><trans-abstract xml:lang="en"><p>Purpose of the study: The aim of the studyis to study the vascular response in response to a test of reactive hyperemia in patients with NAFLD and to identify the relationship of fatty liver damage with endothelial dysfunction. Methods: The study was conducted on the basis of the Irkutsk Regional Order of the Badge of Honor Clinical Hospital, the Angarsk City Clinical Hospital No. 1 and the Consultative and Diagnostic Department No. 1 of the Irkutsk Regional Infectious Diseases Clinical Hospital. Object of study: patients with NAFLD and practically healthy volunteers. All respondents underwent indirect elastometry to diagnose liver fibrosis, and to assess endothelial dysfunction, a sample of reactive hyperemia according to the Celermajer method [<xref ref-type="bibr" rid="cit15">15</xref>]. Statistical analysis of the data obtained was performed in the program Statistica 13 for Windows. Results: The study was conducted in the period 2014-2016. Examined 64 people aged 25 to 64 years with a confirmed diagnosis of NAFLD and 23 practically healthy volunteers aged 25 to 44 years included in the clinical comparison group. Conclusions: 1. Fibrous changes in the liver were more common among middle-aged people and were more pronounced than among younger people; 2. The correlation of fatty liver damage with endothelial dysfunction was revealed - the greater the degree of fibrosis, the stronger the pathological reaction of the vascular wall; 3. The presence of endothelial dysfunction in steatosis has been proven, and, accordingly, the risk of cardiovascular events. Conclusion: the results obtained indicate the connection of pathological processes: liver damage in NAFLD and the development of CVD.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>неалкогольная жировая болезнь печени (НАЖБП)</kwd><kwd>фиброз</kwd><kwd>сердечно-сосудистые заболевания (ССЗ)</kwd><kwd>стеатогепатит</kwd><kwd>стеатоз</kwd><kwd>эндотелиальная дисфункция</kwd></kwd-group><kwd-group xml:lang="en"><kwd>non-alcoholic fatty liver disease (NAFLD)</kwd><kwd>fibrosis</kwd><kwd>cardiovascular diseases (CVD)</kwd><kwd>steatohepatitis</kwd><kwd>steatosis</kwd><kwd>endothelial dysfunctio</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Bueverov A.O., Maevskaya M. V. Some pathogenetic and clinical issues of nonalcoholic steatohepatitis. Clinical Prospects of Gastroenterology, Hepatology. 2003;(3):2-7. (in Russ.) @@Буеверов А. О., Маевская М. В. Некоторые патогенетические и клинические вопросы неалкогольного стеатогепатита // Клинические перспективы гастроэнтерологии, гепатологии. - 2003. - № 3. - С. 2-7.</mixed-citation><mixed-citation xml:lang="en">Bueverov A.O., Maevskaya M. V. Some pathogenetic and clinical issues of nonalcoholic steatohepatitis. Clinical Prospects of Gastroenterology, Hepatology. 2003;(3):2-7. (in Russ.) @@Буеверов А. О., Маевская М. В. Некоторые патогенетические и клинические вопросы неалкогольного стеатогепатита // Клинические перспективы гастроэнтерологии, гепатологии. - 2003. - № 3. - С. 2-7.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Drapkina O.M., Gatsolaeva D. S., Ivashkin V. T. Nonalcoholic fatty liver disease in patients with metabolic syndrome. The clinician. 2007;(6):46-50. (in Russ.) @@Драпкина О. М., Гацолаева Д. С., Ивашкин В. Т. Неалкогольная жировая болезнь печени у больных с метаболическим синдромом // Клиницист. - 2007. - № 6. - C. 46-50.</mixed-citation><mixed-citation xml:lang="en">Drapkina O.M., Gatsolaeva D. S., Ivashkin V. T. Nonalcoholic fatty liver disease in patients with metabolic syndrome. The clinician. 2007;(6):46-50. (in Russ.) @@Драпкина О. М., Гацолаева Д. С., Ивашкин В. Т. Неалкогольная жировая болезнь печени у больных с метаболическим синдромом // Клиницист. - 2007. - № 6. - C. 46-50.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Younossi Z. M. Non-alcoholic fatty liver disease - a global public health perspective. J. Hepatol. 2019;70:531-544. doi: 10.1016/j.jhep.2018.10.033</mixed-citation><mixed-citation xml:lang="en">Younossi Z. M. Non-alcoholic fatty liver disease - a global public health perspective. J. Hepatol. 2019;70:531-544. doi: 10.1016/j.jhep.2018.10.033</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ivashkin V.T., Maevskaya M. V., Pavlov C. S., et al. Clinical guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease of the Russian Society for the Study of the Liver and the Russian Gastroenterological Association.Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2016;26(2):24-42. (in Russ.) doi: 10.22416/1382-4376-2016-26-2-24-42 @@Ивашкин В. Т., Маевская М. В., Павлов Ч. С., Тихонов И. Н., Широкова Е. Н., Буеверов А. О. и др. Клинические рекомендации по диагностике и лечению неалкогольной жировой болезни печени Российского общества по изучению печени и Российской гастроэнтерологической ассоциации. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2016;26(2):24-42. doi: 10.22416/1382-4376-2016-26-2-24-42</mixed-citation><mixed-citation xml:lang="en">Ivashkin V.T., Maevskaya M. V., Pavlov C. S., et al. Clinical guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease of the Russian Society for the Study of the Liver and the Russian Gastroenterological Association.Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2016;26(2):24-42. (in Russ.) doi: 10.22416/1382-4376-2016-26-2-24-42 @@Ивашкин В. Т., Маевская М. В., Павлов Ч. С., Тихонов И. Н., Широкова Е. Н., Буеверов А. О. и др. Клинические рекомендации по диагностике и лечению неалкогольной жировой болезни печени Российского общества по изучению печени и Российской гастроэнтерологической ассоциации. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2016;26(2):24-42. doi: 10.22416/1382-4376-2016-26-2-24-42</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Tirikova O.V., Kozlova N. M., Tarasov A. U., Eliseev S. M., Lunenok S. V. Autopsy incidence rate of fatty liver disease in the Irkutsk region. Experimental and Clinical Gastroenterology. 2020;176(4): 72-76. (In Russ.) doi: 10.31146/1682-8658-ecg-176-4-72-76 @@Тирикова О. В., Козлова Н. М., Тарасов А. Ю., Елисеев С. М., Луненок C. В. Частота встречаемости жировой болезни печени в Иркутской области по результатам аутопсий. Экспериментальная и клиническая гастроэнтерология. 2020;176(4): 72-76. doi: 10.31146/1682-8658-ecg- 176-4-72-76</mixed-citation><mixed-citation xml:lang="en">Tirikova O.V., Kozlova N. M., Tarasov A. U., Eliseev S. M., Lunenok S. V. Autopsy incidence rate of fatty liver disease in the Irkutsk region. Experimental and Clinical Gastroenterology. 2020;176(4): 72-76. (In Russ.) doi: 10.31146/1682-8658-ecg-176-4-72-76 @@Тирикова О. В., Козлова Н. М., Тарасов А. Ю., Елисеев С. М., Луненок C. В. Частота встречаемости жировой болезни печени в Иркутской области по результатам аутопсий. Экспериментальная и клиническая гастроэнтерология. 2020;176(4): 72-76. doi: 10.31146/1682-8658-ecg- 176-4-72-76</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ong J.P., Pitts A., Younossi Z. M. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. Journal of Hepatology. 2008;49 (4):608-612. doi: 10.1016/j.jhep.2008.06.018</mixed-citation><mixed-citation xml:lang="en">Ong J.P., Pitts A., Younossi Z. M. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. Journal of Hepatology. 2008;49 (4):608-612. doi: 10.1016/j.jhep.2008.06.018</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Adams L.A., Lymp J. F., Sauver J. St., Sanderson S. O., Lindor K. D., Feldstein A., et al. The natural history of nonalcoholic fatty liver disease: a population based cohort study. Gastroenterology. 2005;129 (1):113-121. doi: 10.1053/j.gastro.2005.04.014</mixed-citation><mixed-citation xml:lang="en">Adams L.A., Lymp J. F., Sauver J. St., Sanderson S. O., Lindor K. D., Feldstein A., et al. The natural history of nonalcoholic fatty liver disease: a population based cohort study. Gastroenterology. 2005;129 (1):113-121. doi: 10.1053/j.gastro.2005.04.014</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Rafiq N., Bai C., Fang Y., Srishord M., McCullough A., Gramlich T., et al. Long term follow-up of patients with nonalcoholic fatty liver. Clinical Gastroenterology and Hepatology. 2009;7:234-238. doi: 10.1016/j.cgh.2008.11.005</mixed-citation><mixed-citation xml:lang="en">Rafiq N., Bai C., Fang Y., Srishord M., McCullough A., Gramlich T., et al. Long term follow-up of patients with nonalcoholic fatty liver. Clinical Gastroenterology and Hepatology. 2009;7:234-238. doi: 10.1016/j.cgh.2008.11.005</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Medina J., Fernández-Salazar L.I., García-Buey L., Moreno-Otero R. Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis. Diabetes Care. 2004;27(8):2057-2066. doi: 10.2337/diacare.27.8.2057</mixed-citation><mixed-citation xml:lang="en">Medina J., Fernández-Salazar L.I., García-Buey L., Moreno-Otero R. Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis. Diabetes Care. 2004;27(8):2057-2066. doi: 10.2337/diacare.27.8.2057</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Fennessy F. M. Moneley D. S., Wang J. H., Kelly C. J., Bouchier-Hayeset D. J. Taurine and Vitamin C Modify Monocyte and Endothelial Dysfunction in Young Smokers. Circulation. 2003;(107):410-415. (pp. 926-928.) doi: 10.1161/01.cir.0000046447.72402.47</mixed-citation><mixed-citation xml:lang="en">Fennessy F. M. Moneley D. S., Wang J. H., Kelly C. J., Bouchier-Hayeset D. J. Taurine and Vitamin C Modify Monocyte and Endothelial Dysfunction in Young Smokers. Circulation. 2003;(107):410-415. (pp. 926-928.) doi: 10.1161/01.cir.0000046447.72402.47</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Lavi Sh., Egbarya R., Lavi R., Jacobet G. Role of Nitric Oxide in the Regulation of Cerebral Blood Flow in Humans. Circulation. 2003;(107): 1901-1905. doi:10.1161/01.CIR.0000057973.99140.5A</mixed-citation><mixed-citation xml:lang="en">Lavi Sh., Egbarya R., Lavi R., Jacobet G. Role of Nitric Oxide in the Regulation of Cerebral Blood Flow in Humans. Circulation. 2003;(107): 1901-1905. doi:10.1161/01.CIR.0000057973.99140.5A</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Pollock D. M., Polakowski J. S., Opgenorth T. J., Pollock J. S. Role of endothelin ET (A) receptors in the hypertension produced by 4-day L-nitroarginine methyl ester and cyclosporine treatment. Eur. J. Pharmacol. 1998;346(1):43-50. doi: 10.1016/s0014-2999(98)00043-0</mixed-citation><mixed-citation xml:lang="en">Pollock D. M., Polakowski J. S., Opgenorth T. J., Pollock J. S. Role of endothelin ET (A) receptors in the hypertension produced by 4-day L-nitroarginine methyl ester and cyclosporine treatment. Eur. J. Pharmacol. 1998;346(1):43-50. doi: 10.1016/s0014-2999(98)00043-0</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Wattanpitayakul S. K., Weinstein D. M., Holyc ross B.J., Bauer J. A. Endothelial dysfunction and peroxynitrite formation are early events in angiotensin - induced cardiovascular disorders. FASEB J. 2000;14(2):271-278. doi:10.1096/fasebj.14.2.271</mixed-citation><mixed-citation xml:lang="en">Wattanpitayakul S. K., Weinstein D. M., Holyc ross B.J., Bauer J. A. Endothelial dysfunction and peroxynitrite formation are early events in angiotensin - induced cardiovascular disorders. FASEB J. 2000;14(2):271-278. doi:10.1096/fasebj.14.2.271</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Fracanzani A.L., Burdick L., Raselli S., Pedotti P., Grigore L., Santorelli G., et al. Carotid artery intima-media thickness in nonalcoholic fatty liver disease. American Journal of Medicine. 2008;121:72-78. doi: 10.1016/j.amjmed.2007.08.041</mixed-citation><mixed-citation xml:lang="en">Fracanzani A.L., Burdick L., Raselli S., Pedotti P., Grigore L., Santorelli G., et al. Carotid artery intima-media thickness in nonalcoholic fatty liver disease. American Journal of Medicine. 2008;121:72-78. doi: 10.1016/j.amjmed.2007.08.041</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Celermajer D. S., Sorensen K. E., Gooch V. M., Spiegelhalter D. J., Miller O. I., Sullivan I. D., et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992; 340 (8828):1111-1115. doi: 10.1016/0140-6736(92)93147</mixed-citation><mixed-citation xml:lang="en">Celermajer D. S., Sorensen K. E., Gooch V. M., Spiegelhalter D. J., Miller O. I., Sullivan I. D., et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992; 340 (8828):1111-1115. doi: 10.1016/0140-6736(92)93147</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
